Skip to content

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.4×-0.3×
Amgen logo
AmgenAMGN
0.0×
AbbVie logo
AbbVieABBV
0.2×+0.1×
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-0.4×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
2.2×-20.1×

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Calculated from Shattuck Labs, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s cash ratio?
Shattuck Labs, Inc. (STTK) reported cash ratio of 21.3× in Q1 2026.
How has Shattuck Labs, Inc.'s cash ratio changed year-over-year?
Shattuck Labs, Inc.'s cash ratio increased by 155.6% year-over-year, from 8.3× to 21.3×.
What is the long-term trend for Shattuck Labs, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s cash ratio has grown at a -3.9% compound annual growth rate (CAGR), from 9.4× to 7.7×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.